SAN JOSE, Calif., Jan. 20 /PRNewswire-FirstCall/ -- Xilinx, Inc. (Nasdaq: XLNX) today announced record third quarter fiscal 2010 sales of $513.3 million, up 24% sequentially and up 12% from the third quarter of the prior fiscal year. Third quarter net income was $106.9 million, or $0.38 per diluted share, including previously announced restructuring charges totaling $5.5 million, or approximately $0.02 per diluted share. On a year over year basis, third quarter net income and diluted earnings per share declined because in the third quarter of fiscal 2009 there was a $58.3 million pre-tax gain from the early extinguishment of convertible debentures, partially offset by a $19.5 million pre-tax impairment charge on investments.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020822/XLNXLOGO)

The Xilinx Board of Directors announced a quarterly cash dividend of $0.16 per outstanding share of common stock, payable on March 3, 2010 to all stockholders of record at the close of business on February 10, 2010.

Additional third quarter comparisons are represented in the charts below:




    GAAP Results
    (In millions, except EPS)
                                                               Growth Rates
                                 Q3       Q2       Q3
                              FY 2010  FY 2010   FY 2009  Q-T-Q     Y-T-Y
                                                          -----     -----
    Net revenues                $513.3    $415.0   $458.4     24%        12%
    Operating income            $136.6     $82.1   $119.6     66%        14%
    Net income                  $106.9     $64.0   $119.4     67%       -10%
    Diluted earnings per
     share                       $0.38     $0.23    $0.44     65%       -14%

Record sales were driven by strength from all end markets and geographic regions. New Product sales increased 32% sequentially during the quarter due primarily to strong growth from the Virtex®-5 and Spartan®-3 FPGA families.

"It was a record-setting quarter for Xilinx," said Moshe Gavrielov, Xilinx President and Chief Executive Officer. "In addition to record total sales, Xilinx's Virtex-5 family comfortably surpassed $100 million in quarterly sales--more than any other FPGA product in history. Sales strength from this family was driven by Communications, Industrial and Other and Data Processing. Based on new design win activity, I am confident about the prospects for continued sales growth from the Virtex-5 family."




    Net Revenues by Geography:
                                  Percentages                 Growth Rates
                          Q3         Q2          Q3
                        FY 2010    FY 2010    FY 2009    Q-T-Q      Y-T-Y
                        -------    -------    -------    -----      -----
      North America           35%        35%         34%     25%         17%
      Asia Pacific            36%        35%         33%     27%         18%
      Europe                  20%        21%         22%     19%          4%
      Japan                    9%         9%         11%     17%         -7%



    Net Revenues by End Market:


                                     Percentages                Growth Rates
                              Q3         Q2         Q3
                           FY 2010    FY 2010    FY 2009   Q-T-Q     Y-T-Y
                           -------    -------    -------   -----     -----
     Communications              46%        46%        44%     23%        16%
     Industrial & Other          32%        31%        33%     29%         8%
     Consumer & Automotive       15%        16%        16%     15%         2%
     Data Processing              7%         7%         7%     25%        27%




    Net Revenues by Product:
                                     Percentages                Growth Rates
                             Q3          Q2         Q3
                           FY 2010     FY 2010   FY 2009   Q-T-Q      Y-T-Y
                           -------     -------   -------   -----
      New                        33%         31%       21%     32%         72%
      Mainstream                 33%         33%       34%     22%          9%
      Base                       29%         31%       40%     18%        -17%
      Support                     5%          5%        5%     22%          5%



    Products are classified as follows:

    New Products: Virtex-6, Virtex-5, Spartan-6, Spartan-3A and Spartan-
     3E product families
    Mainstream Products: Virtex-4, Spartan-3, Spartan-II and CoolRunner(TM)-
     II product families
    Base Products: Virtex, Virtex-E, Virtex-II, Spartan, XC4000,
     CoolRunner and XC9500 product families
    Support Products: Configuration products, HardWire, Software & Support/
     Services



    Key Statistics:
    (Dollars in millions)
                                      Q3           Q2           Q3
                                   FY 2010      FY 2010      FY 2009
                                   -------      -------      -------

    Annual Return on Equity
     (%)*                                 14           10           20

    Operating Cash Flow                 $185         $118         $128

    Depreciation Expense                 $13          $12          $13

    Capital Expenditures                  $9           $4          $11

    Combined Inventory Days               85           75           99

    Revenue Turns (%)                     58           57           54
    *Return on equity calculation: Annualized net income/average
     stockholders' equity

Product and Financial Highlights

    --  Building upon Virtex-5 success, Xilinx today announced that its Virtex-6
        family has achieved full production qualification and is commencing
        volume shipments.  Xilinx also recently announced first shipments and
        availability of the industry's largest FPGA, the 40-nm LX760, which is
        ideal for use in advanced prototyping platforms and the ASIC emulation
        market.
    --  On October 19, 2009, Xilinx and ARM announced they are collaborating to
        enable ARM processor and interconnect technology on Xilinx FPGA
        products.  This agreement is expected to allow programmable solutions to
        penetrate even deeper into existing markets and expand into new market
        spaces by leveraging ARM's processor strengths and ecosystem.
    --  On December 8, 2009, Xilinx announced six new Targeted Design Platform
        development kits for the Virtex-6 and Spartan-6 product families.  The
        new kits increase productivity and innovation for electronic designers
        in the areas of target embedded processing, DSP and high speed serial
        connectivity.
    --  December quarter operating margin was 27%, up from 20% in the prior
        quarter and the highest reported by the Company in four years.  Improved
        customer demand and continued spending discipline contributed to the
        operating margin increase.

Business Outlook - March Quarter Fiscal 2010


    --  Sales are expected to be up 3% sequentially to down 1% sequentially.
    --  Gross margin is expected to be approximately 64% to 65%.
    --  Operating expenses are expected to be approximately $180 million,
        including $3 million in previously announced restructuring charges.
    --  Other income and expense is expected to be a net expense of
        approximately $2 million.
    --  Fully diluted share count is expected to be approximately 275 million.
    --  March quarter tax rate is expected to be approximately 20%.

Conference Call

A conference call will be held today at 2:00 p.m. Pacific Time to discuss the quarter's results and management's outlook for the March quarter. The webcast and subsequent replay will be available in the investor relations section of the company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (800) 642-1687 and referencing confirmation code 47787165. The telephonic replay will be available for two weeks following the live call.

This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as "expect," "may," "will," "could," "believe," "anticipate," "estimate," "continue," "plan," "intend," "project" or other similar words. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including the general health of global economies as well as of the semiconductor industry, the health of our end markets and our customers' customers, the ability of our foundry suppliers to deliver sufficient wafer volumes in a timely manner, our ability to forecast end customer demand, customer acceptance of our new products, the ability of the Company to generate cost and operating expense savings in an efficient and timely fashion, the ability of our customers to manage their inventories, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, and other risk factors listed in our most recent Forms 10-K and 10-Q.

About Xilinx

Xilinx, Inc. (NASDAQ: XLNX) is the worldwide leader of programmable logic solutions. Additional information about Xilinx is available athttp://www.xilinx.com.

Xilinx, the Xilinx logo, Virtex, Spartan, ISE, and other brands designated herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.

#1004F



    Investor Relations Contact:
    Lori Owen
    Xilinx, Inc.
    (408) 879-6911
    ir@xilinx.com


    XILINX, INC.
    CONDENSED CONSOLIDATED STATEMENTS OF INCOME
    (Unaudited)
    (In thousands, except per share amounts)


                                            Three Months Ended
                                            ------------------
                                          Jan. 2,     Dec. 27, Sept. 26,
                                                2010    2008*         2009
    Net revenues                            $513,349     $458,387 $414,950
    Cost of revenues                         184,320      165,331  158,177
                                             -------      -------  -------
    Gross margin                             329,029      293,056  256,773
                                             -------      -------  -------
    Operating expenses:
      Research and development               101,867       86,967   90,145
      Selling, general and administrative     85,037       85,032   78,621
      Amortization of acquisition-related
       intangibles                                 -        1,475        -
      Restructuring charges                    5,531            -    5,915
                                               -----          ---    -----
        Total operating expenses             192,435      173,474  174,681
                                             -------      -------  -------

    Operating income                         136,594      119,582   82,092
    Impairment loss on investments            (3,041)     (19,540)       -
    Gain on early extinguishment of
     convertible debentures                        -       58,290        -
    Interest and other income (expense),
     net                                        (542)      (1,743)  (1,782)
                                                ----       ------   ------

    Income before income taxes               133,011      156,589   80,310
    Provision for income taxes                26,103       37,145   16,272
                                              ------       ------   ------
    Net income                              $106,908     $119,444  $64,038
                                            ========     ========  =======

    Net income per common share:
      Basic                                    $0.39        $0.44    $0.23
                                               =====        =====    =====
      Diluted                                  $0.38        $0.44    $0.23
                                               =====        =====    =====

    Cash dividends declared per common
     share                                     $0.16        $0.14    $0.14
                                               =====        =====    =====

    Shares used in per share
     calculations:
      Basic                                  276,832      273,997  276,353
                                             =======      =======  =======
      Diluted                                278,566      274,223  276,988
                                             =======      =======  =======



                                                      Nine Months Ended
                                                      -----------------
                                                Jan. 2,          Dec. 27,
                                                      2010        2008*
                                                      ----        -----
    Net revenues                                $1,304,534         $1,430,170
    Cost of revenues                               486,319            519,244
                                                   -------            -------
    Gross margin                                   818,215            910,926
                                                   -------            -------
    Operating expenses:
      Research and development                     275,245            267,202
      Selling, general and administrative          237,214            266,116
      Amortization of acquisition-related
       intangibles                                   2,493              4,326
      Restructuring charges                         27,217             22,023
                                                    ------             ------
        Total operating expenses                   542,169            559,667
                                                   -------            -------

    Operating income                               276,046            351,259
    Impairment loss on investments                  (3,041)           (53,162)
    Gain on early extinguishment of convertible
     debentures                                          -             58,290
    Interest and other income (expense), net       (13,234)             9,975
                                                   -------              -----

    Income before income taxes                     259,771            366,362
    Provision for income taxes                      50,819             82,680
                                                    ------             ------
    Net income                                    $208,952           $283,682
                                                  ========           ========

    Net income per common share:
      Basic                                          $0.76              $1.03
                                                     =====              =====
      Diluted                                        $0.75              $1.02
                                                     =====              =====

    Cash dividends declared per common share         $0.44              $0.42
                                                     =====              =====

    Shares used in per share calculations:
      Basic                                        275,989            276,584
                                                   =======            =======
      Diluted                                      277,030            277,603
                                                   =======            =======


      * As adjusted due to the retrospective adoption of the accounting
      standard for convertible debentures in the first quarter of fiscal
      2010.



    XILINX, INC.
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (In thousands)
                                                    Jan. 2,        March 28,
                                                          2010       2009*
                                                          ----       -----
                                                  (Unaudited)

    ASSETS
    Current assets:
      Cash, cash equivalents and short-term
       investments                                  $1,489,993      $1,324,933
      Accounts receivable, net                         231,078         216,390
      Inventories                                      128,935         119,832
      Deferred tax assets and other current
       assets                                          108,720          91,313
                                                       -------          ------
    Total current assets                             1,958,726       1,752,468
    Net property, plant and equipment                  367,514         387,907
    Long-term investments                              503,106         347,787
    Other assets                                       292,605         323,739
                                                       -------         -------
    Total Assets                                    $3,121,951      $2,811,901
                                                    ==========      ==========

    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
      Accounts payable and accrued  liabilities       $284,573        $170,702
      Deferred income on shipments to
       distributors                                     77,395          62,364
                                                        ------          ------
    Total current liabilities                          361,968         233,066
    Convertible debentures                             354,460         352,110
    Deferred tax liabilities                           247,822         196,189
    Other long-term liabilities                        123,793          81,776
    Stockholders' equity                             2,033,908       1,948,760
                                                     ---------       ---------
    Total Liabilities and Stockholders' Equity      $3,121,951      $2,811,901
                                                    ==========      ==========

    *  Derived from audited financial statements and adjusted for the
     retrospective adoption of the accounting standard for convertible
     debentures  in the first quarter of fiscal 2010.


    XILINX, INC.
    SUPPLEMENTAL FINANCIAL INFORMATION
    (Unaudited)


    (In thousands)                           Three Months Ended
                                             ------------------
                                           Jan. 2,    Dec. 27, Sept. 26,
                                                2010    2008*        2009
                                                ----    -----        ----

    SELECTED CASH FLOW INFORMATION:
      Depreciation                           $12,867     $13,438  $12,056
      Amortization                             3,210       4,069    3,260
      Stock-based compensation                15,519      13,041   11,762
      Net cash provided by operating
       activities                            185,478     128,479  117,976
      Purchases of property, plant and
       equipment                              (8,693)    (11,061)  (4,133)
      Payment of dividends to stockholders   (44,299)    (38,357) (38,744)
      Repurchases of common stock            (25,000)          -        -
      Proceeds from issuance of common
       stock to employees and excess tax
       benefit                                13,546       2,992   15,677

    STOCK-BASED COMPENSATION INCLUDED IN:
      Cost of revenues                        $1,291      $1,337   $1,272
      Research and development                 7,289       6,055    5,205
      Selling, general and administrative      6,939       5,649    5,285
      Restructuring charges                        -           -        -



    (In thousands)                                  Nine Months Ended
                                                    -----------------
                                                 Jan. 2,      Dec. 27,
                                                      2010     2008*
                                                      ----     -----

    SELECTED CASH FLOW INFORMATION:
      Depreciation                                 $37,932      $42,167
      Amortization                                  11,777       12,420
      Stock-based compensation                      41,010       41,188
      Net cash provided by operating activities    450,421      381,676
      Purchases of property, plant and equipment   (17,540)     (32,711)
      Payment of dividends to stockholders        (121,617)    (115,982)
      Repurchases of common stock                  (25,000)    (275,000)
      Proceeds from issuance of common stock to
       employees and excess tax benefit             13,167       84,379

    STOCK-BASED COMPENSATION INCLUDED IN:
      Cost of revenues                              $3,678       $4,416
      Research and development                      18,140       18,702
      Selling, general and administrative           18,247       17,506
      Restructuring charges                            945          564


    * As adjusted due to the retrospective adoption of the accounting
    standard for convertible debentures in the first quarter of fiscal
    2010

SOURCE Xilinx, Inc.